OCT’s Pharmacovigilance team covers a range of clinical trial safety monitoring and safety reporting tasks and responsibilities for our clients’ studies.
We coordinate and centralize all safety issues and all pharmacovigilance tasks to perform the management of safety information during the course of a clinical trial. Our expertise guarantees that all safety information (Serious Adverse Event (SAE) and other cases) is collected and reported to the appropriate individuals and organizations within the required timelines on all studies we conduct for our clients.
OCT Pharmacovigilance services include:
As a result, we bring together our PVG process expertise and the regulatory insights to deliver safety reports of high quality on time and in compliance with the sponsor’s budget.